North America’s Most Awarded Contract Drug Substance Manufacturer
24 Life Science Leader CMO awards from 2014-2017
Click and view our video series on How to Select a CMO.
COMPANY OVERVIEW
PCI Synthesis, part of SEQENS CDMO is one of the most awarded cGMP Contract API manufacturing companies that offers you everything you need from initial process research to commercial API manufacturing. We have more than 20 years of experience in contract chemical manufacturing, which has enabled us to develop deep expertise in custom NCEs, controlled substances (Schedule II-V), generic APIs, and custom manufactured fine chemicals. PCI combines the responsiveness of a small company with the capacity and capabilities of a much larger one.
IN THE NEWS
October 26, 2021
The Quality Imperative in API Manufacturing
October 19, 2021
Tech Transfer Can Be a Tricky Thing
March 25, 2020
Evolution is Essential in the Dynamic Pharmaceutical Industry
December 13, 2019
The Surge in Chinese Biotech Requires Collaboration and Cooperation on a Global Level
December 17, 2021
Change in SEQENS’ shareholding structure
October 12, 2021
Quality in a Time of EUAs and Fast-Track Drugs
October 5, 2021
Seqens CDMO’s Cooperative Arrangements with Colleges and Universities Continue to Pay Off
September 28, 2021
The Fine Science of Manufacturing APIs for Injectables
September 14, 2021
At the Helm of Seqens CDMO North America
September 14, 2021
Seqens Appoints Bob Huang Managing Director of North American CDMO Operations
UPCOMING EVENTS
Click on an event below to arrange a meeting with PCI